Skip to main content
Clinical Trials/IRCT20181022041406N1
IRCT20181022041406N1
Completed
未知

Catheter directed thrombolysis versus anticoagulation only in patients with Intermediate-high risk pulmonary emboli-A randomized clinical trial

Rajaie Cardiovascular Medical and Research Center0 sites288 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Pulmonary emboli.
Sponsor
Rajaie Cardiovascular Medical and Research Center
Enrollment
288
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rajaie Cardiovascular Medical and Research Center

Eligibility Criteria

Inclusion Criteria

  • Men and women \= 18 year\-old
  • Acute pulmonary emboli must be confirmed with pulmonary CT angiography
  • Symptoms onset \= 14 days
  • Elevated pro b\-type natriuretic peptide and cardiac troponin
  • Right ventricle/left ventricle ratio in pulmonary CT angiography \>0\.9
  • simplified pulmonary embolism severity index score \>\=1
  • Less than 48 hours of anticoagulation therapy

Exclusion Criteria

  • Pulmonary emboli diagnosed with other modalities than pulmonary CT angiography
  • High risk (massive) pulmonary Emboli
  • Segmental pulmonary emboli
  • Patient with terminal illness
  • Surgery within 2 weeks
  • Severe renal dysfunction (creatinine clearance \[CrCl] below 30 mL/min)
  • Platelet count \<50\.000
  • Thrombolytic contraindication
  • Concomitant right heart thrombosis
  • Pre and post catheter directed thrombolysis echocardiography exam not possible

Outcomes

Primary Outcomes

Not specified

Similar Trials